Altss / Licensed company reference
Ginkgo Bioworks
Ginkgo Bioworks appears in Unitard Club's October 23, 2026 press dataset under public market decline. This is a licensed source reference, distinct from an independently researched Altss case.
Licensed reference / Source snapshot Oct 23, 2026
The category and benchmark below are reported by Unitard. They have not received the independent financial investigation required for an Altss research case.
Identity and known-contradiction screen recorded Oct 26, 2026. The source snapshot is not the event date.
Unitard-reported historical benchmark
~$15bnSource-reported benchmark year: 2021 · Nominal US dollars, rounded
The licensed source note ties the approximate benchmark amount to a SPAC transaction valuation. Its underlying financial source was not independently rechecked; this does not establish a private financing or a traded market-cap peak.
Basis: SPAC transaction benchmark (source-indicated). The dataset mixes private financing, SPAC transaction values and public market capitalization.
Source CSV ↗Source classification
Public market declineUnitard snapshot .
This is a source classification, not an independently verified Altss event or an assertion of present value or solvency.
Unitard source entry ↗This source-reported figure does not independently establish a private unicorn valuation, a verified peak or current value. Different valuation bases cannot be subtracted to calculate investor losses.
Company identity
Ginkgo Bioworks is identified through its linked official company website. The licensed source describes this as a SPAC transaction benchmark, which does not establish a billion-dollar private financing.
Identity evidence · Accessed Oct 26, 2026
Country and sector are normalized dataset classifications. A brand or website may continue under a new owner; its availability does not verify the financial benchmark.
Provenance and attribution
Adapted from Unitard Club (unitard.io), CC BY 4.0 press dataset, dated Oct 23, 2026; collected Oct 26, 2026. Altss adds selection, identity screening, normalization and presentation.
Restricted investor columns, original summaries, decline percentages, investor-loss totals and unverified source prose are excluded. Company marks identify their respective owners and imply no affiliation or endorsement.
Logo: Ginkgo Bioworks logo source. Company trademark rights remain.